Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C30H35F7N4O3 |
| Molecular Weight | 632.6127 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](N(C)C(=O)N1CC[C@@H](C[C@@H]1C2=CC=C(F)C=C2C)N3CCN(C(O)C3)C(C)=O)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
InChI
InChIKey=IMIUKXZVUAUOBR-GFILMBHASA-N
InChI=1S/C30H35F7N4O3/c1-17-11-23(31)5-6-25(17)26-15-24(39-9-10-40(19(3)42)27(43)16-39)7-8-41(26)28(44)38(4)18(2)20-12-21(29(32,33)34)14-22(13-20)30(35,36)37/h5-6,11-14,18,24,26-27,43H,7-10,15-16H2,1-4H3/t18-,24+,26-,27?/m1/s1
| Molecular Formula | C30H35F7N4O3 |
| Molecular Weight | 632.6127 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 05:46:38 GMT 2025
by
admin
on
Wed Apr 02 05:46:38 GMT 2025
|
| Record UNII |
V7P59U95XA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
12001280
Created by
admin on Wed Apr 02 05:46:38 GMT 2025 , Edited by admin on Wed Apr 02 05:46:38 GMT 2025
|
PRIMARY | |||
|
V7P59U95XA
Created by
admin on Wed Apr 02 05:46:38 GMT 2025 , Edited by admin on Wed Apr 02 05:46:38 GMT 2025
|
PRIMARY | |||
|
921765-80-2
Created by
admin on Wed Apr 02 05:46:38 GMT 2025 , Edited by admin on Wed Apr 02 05:46:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
after oral administration, at 1h
MAJOR
PLASMA
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
| Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||